Antibiotic Resistance: From the Bench to Patients
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: closed (31 May 2020) | Viewed by 58551
Special Issue Editors
2. Department of Organic Chemistry, University of Barcelona, CIBER-BBN, Barcelona, Spain
Interests: antimicrobial peptides; solid-phase chemistry; combinatorial chemistry; drug delivery systems; peptide drug conjugates; orthogonal chemistry; drug discovery; biomaterials
Special Issues, Collections and Topics in MDPI journals
Interests: epidemiology; clinical microbiology; resistance trends; UTIs, antimicrobial stewardship; knowledge-attitude-practice (KAP); novel antimicrobials; drug design; anaerobes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The emergence of multidrug-resistant (MDR) bacteria is a serious public health issue which requires global action of an intersectoral nature, involving physicians, pharmacists, patients, and the relevant stakeholders alike. As pharmaceutical companies are struggling to keep up with the increase in the resistance trends of various pathogens (most commonly termed “ESKAPE” bacteria), the conscious use of the existing antimicrobials (both qualitatively and quantitatively) is of utmost importance. General practitioners and community pharmacists usually represent the first-line of interaction with healthcare for most of the patients; therefore, they need to act as “gate keepers” while prescribing/dispensing antibiotics. The appropriateness of the healthcare professionals’ knowledge–attitude–practice (KAP) is critical for proper patient education and for attaining change in their attitudes. In addition, clinical microbiology laboratories have pivotal roles in reporting the epidemiological features of their region, in performing antimicrobial susceptibility testing, and in the detection of relevant resistance mechanisms, supplying important information to physicians in a clinically-relevant time frame, also, to support infection control measures to curb the spread of drug resistant bacteria.
The purpose of this Special Issue is to present novel results on the epidemiology of various MDR pathogens worldwide, to describe novel diagnostic and point-of-care (POCT) tests to aid proper antibiotic therapy, interventional studies to improve antimicrobial drug utilization, pharmacoepidemiological studies, and various studies reporting on the knowledge, attitude, and practice of healthcare professionals (nurses, doctors, pharmacists, etc.) and patients regarding antibiotics and antibiotic resistance.
Prof. Dr. Fernando Albericio
Dr. Márió Gajdács
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotic resistance
- MDR
- ESKAPE pathogens
- resistance detection
- point-of-care testing (POCT)
- clinical bacteriology
- infectious disease epidemiology
- drug utilization
- antimicrobial stewardship
- attitudes on antimicrobials
- knowledge on antimicrobials
- regulatory perspectives
- policy analysis
- primary care
- pharmacy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.